marketcaparena

AVXL

ANAVEX LIFE SCIENCES CORP.

Company overview

Market capitalization
$217.78M
Employees
34
Latest publication
2026-09-29
About ANAVEX LIFE SCIENCES CORP.

Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, pain, and various types of cancer . Its lead drug candidate, ANAVEX 2-73 (blarcamesine), has completed a Phase 2a and a Phase 2b/3 clinical trial for Alzheimer's disease; a Phase 2 proof-of-concept study in Parkinson's disease dementia; and a Phase 2 and a Phase 3 study in adult patients and one Phase 2/3 study in pediatric patients with Rett syndrome. Its ANAVEX 2-73 is an orally available drug candidate designed to restore cellular homeostasis by targeting SIGMAR1 and muscarinic receptors. The ANAVEX 2-73 also exhibited anticonvulsant, anti-amnesic, neuroprotective, and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, including epilepsy. The company's ANAVEX 3-71, which targets SIGMAR1 and M1 muscarinic receptors, is a clinical stage drug candidate demonstrating disease-modifying activity against Alzheimer's disease in transgenic (3xTg-AD) mice, including cognitive deficits, amyloid, and tau pathologies. Anavex Life Sciences Corp. was incorporated in 2004 and is headquartered in New York, New York.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ3 20262026-06-30 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USDQ3 20242024-06-30 · USD
Total operating expenses (recovery)-6,737,000USD———————
Basic92,696,842,000shares———————
Income (loss)7,824,000USD———————
Diluted92,899,536,000shares———————
Income (Loss) from operations6,737,000USD———————
General and administrative (recovery)-2,032,000USD———————
Total other income, net1,087,000USD———————
Research and development (recovery)-4,705,000USD———————
Total Revenue—0USD0USD0USD0USD0USD0USD0USD
Research Development—4,656,000USD7,294,000USD9,959,000USD9,892,000USD10,446,000USD11,555,000USD11,811,000USD
Selling General Administrative—2,126,000USD3,550,000USD4,500,000USD2,621,000USD3,146,000USD2,781,000USD2,792,000USD
Total Operating Expenses—6,782,000USD10,844,000USD14,459,000USD12,513,000USD13,592,000USD14,336,000USD14,603,000USD
Operating Income—-6,782,000USD-10,844,000USD-14,459,000USD-12,513,000USD-13,592,000USD-14,336,000USD-14,603,000USD
Interest Income—1,079,000USD999,000USD1,075,000USD1,210,000USD1,394,000USD1,759,000USD1,796,000USD
Net Interest Income—1,079,000USD999,000USD1,075,000USD1,210,000USD1,394,000USD1,759,000USD1,796,000USD
Income Before Tax—-5,663,000USD-9,827,000USD-13,243,000USD-11,196,000USD-12,111,000USD-11,744,000USD-12,214,000USD
Income Tax Expense—18,000USD—-127,000USD-96,000USD-412,000USD-124,000USD-67,000USD
Tax Provision—18,000USD———0USD-124,000USD-67,000USD
Net Income—-5,681,000USD-9,827,000USD-13,243,000USD-11,196,000USD-12,111,000USD-11,620,000USD-12,214,000USD
Net Income From Continuing Ops—-5,681,000USD-9,827,000USD-13,243,000USD-11,196,000USD-12,111,000USD-11,620,000USD-12,214,000USD
Ebitda—-5,663,000USD-6,485,000USD-14,307,000USD-12,417,000USD-13,580,000USD-11,744,000USD-14,077,000USD
Total Other Income Expense Net—1,119,000USD1,017,000USD1,216,000USD1,317,000USD1,481,000USD2,592,000USD2,389,000USD
Ebit————-11,292,000USD-12,523,000USD-11,271,000USD-26,471,000USD
Depreciation And Amortization————12,417,000USD1,057,000USD-22,748,000USD14,203,000USD
Interest Expense——————0USD0USD
SourceDisclosurePreliminaryLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USDFY 20192019-09-30 · USDFY 20182018-09-30 · USDFY 20172017-09-30 · USD
Total Revenue0USD0USD0USD0USD0USD-685,000USD0USD0USD
Research Development37,592,000USD43,717,000USD37,916,000USD32,984,000USD25,231,623USD22,260,349USD13,344,421USD10,672,086USD
Selling General Administrative13,816,000USD12,039,000USD13,070,000USD9,018,000USD5,856,609USD6,846,599USD5,989,170USD5,008,275USD
Total Operating Expenses51,408,000USD55,756,000USD50,986,000USD42,002,000USD30,938,344USD28,808,005USD19,184,536USD15,539,419USD
Operating Income-51,408,000USD-47,498,000USD-50,986,000USD-42,002,000USD-31,088,232USD-28,752,000USD-19,185,000USD-15,539,000USD
Interest Income4,678,000USD6,519,000USD946,988USD26,261USD179,973USD207,280USD255,092USD88,098USD
Interest Expense0USD964,000USD946,988USD4,038,672USD4,806,078USD151,133USD30,943USD0USD
Net Interest Income4,678,000USD5,555,000USD946,988USD26,261USD179,973USD56,147USD224,149USD88,098USD
Income Before Tax-46,377,000USD-47,498,000USD-47,620,000USD-37,641,000USD-26,257,806USD-26,212,798USD-17,380,663USD-13,400,798USD
Income Tax Expense-648,000USD-7,000USD358,000USD268,000USD22,664USD82,181USD72,746USD59,607USD
Net Income-46,377,000USD-47,491,000USD-47,978,000USD-37,909,000USD-26,280,470USD-26,294,979USD-17,453,409USD-13,460,405USD
Net Income From Continuing Ops-46,377,000USD-47,505,000USD-47,977,919USD-37,908,634USD-26,280,470USD-26,294,979USD-17,453,409USD-13,460,405USD
Ebitda-46,377,000USD-47,498,000USD-47,620,000USD-37,641,000USD-31,063,884USD-28,881,374USD-19,134,747USD-15,567,040USD
Total Other Income Expense Net5,031,000USD2,678,000USD3,366,000USD4,361,000USD4,500,565USD2,539,060USD1,579,724USD2,050,523USD
Selling And Marketing Expenses—118,000USD73,000USD131,000USD——151,405USD127,993USD
Tax Provision—7,000USD358,492USD267,565USD22,664USD82,181USD72,746USD59,607USD
Ebit—-47,498,000USD-47,619,000USD-74,830,000USD-57,777,000USD-55,522,000USD-36,638,000USD-15,568,252USD
Depreciation And Amortization—-2,718USD-3,323,000USD37,455,000USD26,713,000USD26,641,000USD17,503,000USD1,252USD
Net Income Applicable To Common Shares—-47,505,000USD-47,977,919USD-37,908,634USD-26,280,470USD-26,294,979USD-17,252,736USD-13,460,405USD
Non Operating Income Net Other——2,419,400USD4,333,855USD4,650,453USD2,686,870USD1,697,836USD2,191,465USD
Cost Of Revenue——————0USD0USD
Gross Profit——————0USD0USD
Reconciled Depreciation——————0USD—
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ3 20262026-06-30 · USDQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USD
Total Assets120,139,000USD128,766,000USD132,989,000USD103,815,000USD102,432,000USD117,139,000USD124,043,000USD135,567,000USD
Cash And Equivalents118,326,000USD127,422,000USD—102,577,000USD————
Other Current Assets818,000USD412,000USD396,000USD429,000USD-820,000USD702,000USD711,000USD931,000USD
Total Liabilities7,692,000USD7,059,000USD—8,946,000USD————
Other Current Liabilities4,036,000USD3,734,000USD—3,892,000USD————
Total Stockholder Equity112,447,000USD121,707,000USD126,618,000USD94,869,000USD90,958,000USD99,758,000USD110,915,000USD120,263,000USD
Total Equity Including Noncontrolling Interest112,447,000USD121,707,000USD—94,869,000USD————
Accounts Payable3,656,000USD2,520,000USD2,639,000USD4,249,000USD6,740,000USD6,997,000USD4,567,000USD9,627,000USD
Common Stock93,000USD93,000USD93,000USD87,000USD85,000USD85,000USD85,000USD85,000USD
Retained Earnings-385,643,000USD-393,467,000USD-388,129,000USD-382,448,000USD-372,621,000USD-359,378,000USD-348,182,000USD-336,071,000USD
Total Liab——6,371,000USD—11,474,000USD17,381,000USD13,128,000USD15,304,000USD
Other Current Liab——2,927,000USD—3,929,000USD9,555,000USD7,732,000USD4,835,000USD
Capital Stock——93,000USD—85,000USD85,000USD85,000USD85,000USD
Cash——131,749,000USD—101,164,000USD115,771,000USD120,775,000USD132,187,000USD
Cash And Short Term Investments——131,749,000USD—101,164,000USD115,771,000USD120,775,000USD132,187,000USD
Total Current Assets——132,989,000USD—101,164,000USD117,139,000USD124,043,000USD135,567,000USD
Total Current Liabilities——6,371,000USD—11,474,000USD17,381,000USD13,128,000USD15,304,000USD
Current Deferred Revenue——805,000USD—805,000USD829,000USD829,000USD842,000USD
Net Debt——-131,749,000USD—-101,164,000USD-115,771,000USD-120,775,000USD-132,187,000USD
Net Receivables——844,000USD—820,000USD666,000USD2,557,000USD2,449,000USD
Common Stock Shares Outstanding——89,029,458shares—85,380,587shares85,073,769shares84,806,000shares84,002,000shares
Non Current Assets Total——0USD—0USD0USD0USD3,380,000USD
Non Current Liabilities Total——2,927,000USD—3,929,000USD9,555,000USD7,732,000USD4,835,000USD
Net Working Capital——126,618,000USD—90,958,000USD99,758,000USD110,915,000USD120,263,000USD
Unclassified Non Current Liabilities——2,927,000USD—3,929,000USD9,555,000USD7,732,000USD4,835,000USD
Unclassified Equity——514,561,000USD—463,409,000USD458,966,000USD458,927,000USD456,164,000USD
Other Assets————1,268,000USD1,368,000USD3,268,000USD—
Unclassified Non Current Assets————-1,268,000USD-1,368,000USD-3,268,000USD3,380,000USD
SourceDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyDisclosureDeterministicAmendmentLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USDFY 20192019-09-30 · USDFY 20182018-09-30 · USD
Total Assets103,815,000USD135,567,000USD154,386,000USD152,704,603USD161,616,490USD34,542,197USD25,329,373USD24,376,136USD
Cash And Equivalents102,577,000USD———————
Other Current Assets429,000USD931,000USD653,000USD354,162USD355,549USD443,839USD3,143,743USD1,251,798USD
Total Liabilities8,946,000USD———————
Other Current Liabilities3,892,000USD———————
Total Stockholder Equity94,869,000USD120,263,000USD141,852,000USD142,491,042USD150,818,104USD27,236,569USD20,289,699USD20,491,510USD
Total Equity Including Noncontrolling Interest94,869,000USD———————
Accounts Payable4,249,000USD9,627,000USD4,322,000USD3,824,777USD4,739,781USD3,989,054USD3,523,332USD2,955,293USD
Common Stock87,000USD85,000USD82,000USD77,944USD75,920USD62,047USD52,652USD45,935USD
Retained Earnings-382,448,000USD-336,071,000USD-293,069,000USD-245,563,783USD-197,585,864USD-159,677,230USD-133,396,760USD-108,931,967USD
Total Liab—15,304,000USD12,534,000USD10,214,000USD10,798,386USD7,305,628USD5,039,674USD3,884,626USD
Other Current Liab—4,835,000USD7,295,000USD5,944,953USD5,614,774USD3,316,574USD1,516,342USD929,333USD
Capital Stock—85,000USD82,000USD77,944USD75,920USD62,047USD52,652USD45,935USD
Other Assets—3,380,000USD-3,362,000USD-3,546,742,000USD-16,365USD-5,293,179USD—153,529USD
Cash—132,187,000USD151,024,000USD149,157,861USD152,107,745USD29,249,018USD22,185,630USD22,930,638USD
Cash And Short Term Investments—132,187,000USD151,024,000USD149,157,861USD152,107,745USD29,249,018USD22,185,630USD22,930,638USD
Total Current Assets—135,567,000USD154,386,000USD152,704,603USD161,616,490USD34,542,197USD25,329,373USD24,323,740USD
Total Current Liabilities—15,304,000USD12,534,000USD10,213,561USD10,798,386USD7,305,628USD5,039,674USD3,884,626USD
Current Deferred Revenue—842,000USD917,000USD443,831USD443,831USD———
Net Debt—-132,187,000USD-151,024,000USD-149,157,861USD-152,107,745USD-29,249,018USD-22,185,630USD-22,930,638USD
Net Receivables—2,449,000USD2,709,000USD3,193,000USD9,136,831USD4,849,340USD2,642,745USD1,870,357USD
Common Stock Shares Outstanding—83,468,000shares79,788,000shares76,910,000shares69,803,000shares58,195,000shares48,906,000shares44,656,000shares
Non Current Assets Total—0USD3,362,000USD3,546,742,000USD16,365USD5,293,179USD0USD52,396USD
Non Current Liabilities Total—4,835,000USD7,295,000USD4,268,608USD-386USD3,316,574USD1,516,342USD0USD
Net Working Capital—120,263,000USD141,852,000USD142,491,042USD150,818,104USD27,236,569USD20,289,699USD20,439,114USD
Unclassified Non Current Assets—-3,380,000USD——————
Unclassified Non Current Liabilities—4,835,000USD7,295,000USD3,824,777USD—3,316,574USD1,516,342USD—
Unclassified Equity—456,164,000USD434,757,000USD387,898,937USD348,252,128USD186,789,705USD153,581,155USD129,331,607USD
Accumulated Other Comprehensive Income——0USD0USD0USD——0USD
Non Currrent Assets Other——3,362,000USD3,546,742,000USD16,365USD5,293,179USD0USD52,396USD
Net Tangible Assets——141,852,000USD142,491,042USD150,818,104USD27,236,569USD20,289,699USD22,321,696USD
Deferred Long Term Liab———443,831USD443,831USD——101,133USD
Inventory————16,365USD—-2,642,745USD0USD
Unclassified Current Assets——————-2,642,745USD-1,729,053USD
Intangible Assets———————0USD
Good Will———————0USD
Long Term Debt———————0USD
Short Term Investments———————0USD
Property Plant Equipment Net———————0USD
Additional Paid In Capital———————0USD
Treasury Stock———————0USD
SourceDisclosureDeterministicAmendmentLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow YTD

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ3 20262026-06-30 · USDQ2 20262026-03-31 · USD
Stock Based Compensation-15,663,000USD1,421,000USD
Change To Liabilities-1,254,000USD-1,887,000USD
Change In Working Capital-593,000USD-1,729,000USD
Operating Cash Flow-20,687,000USD-11,591,000USD
Financing Cash Flow36,436,000USD36,436,000USD
Change In Cash15,749,000USD24,845,000USD
End Cash Flow118,326,000USD127,422,000USD
SourceDisclosureDeterministicFinalDisclosureDeterministicFinal

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USDQ3 20242024-06-30 · USDQ2 20242024-03-31 · USD
Net Income-5,681,000USD-9,827,000USD-13,243,000USD-11,196,000USD-12,111,000USD-11,620,000USD-12,214,000USD-10,546,000USD
Stock Based Compensation1,107,000USD3,721,000USD4,324,000USD1,449,000USD2,055,000USD2,013,000USD2,487,000USD2,652,000USD
Change To Account Receivables-35,000USD11,000USD-154,000USD1,891,000USD-108,000USD-729,000USD2,065,000USD-236,000USD
Change In Working Capital-2,577,000USD-2,498,000USD-3,545,000USD3,891,000USD-2,064,000USD2,890,000USD4,606,000USD-3,762,000USD
Total Cash From Operating Activities-7,151,000USD-8,604,000USD-12,464,000USD-5,856,000USD-12,120,000USD-6,658,000USD-5,180,000USD-11,656,000USD
Capital Expenditures0USD0USD0USD0USD0USD0USD0USD0USD
Free Cash Flow-7,151,000USD-8,604,000USD-12,464,000USD-5,856,000USD-12,120,000USD-6,658,000USD-5,180,000USD-11,656,000USD
Total Cash From Financing Activities36,323,000USD10,017,000USD-2,143,000USD852,000USD708,000USD89,000USD4,550,000USD7,277,000USD
Issuance Of Capital Stock36,323,000USD9,198,000USD0USD0USD0USD0USD4,106,000USD—
Change In Cash29,172,000USD1,413,000USD-14,607,000USD-5,004,000USD-11,412,000USD-6,569,000USD-630,000USD-4,379,000USD
Begin Period Cash Flow102,577,000USD101,164,000USD115,771,000USD120,775,000USD132,187,000USD138,756,000USD139,386,000USD143,765,000USD
End Period Cash Flow131,749,000USD102,577,000USD101,164,000USD115,771,000USD120,775,000USD132,187,000USD138,756,000USD139,386,000USD
Other Cashflows From Financing Activities—-445,000USD-2,262,000USD852,000USD708,000USD89,000USD444,000USD7,277,000USD
Unclassified Financing Cash Flow—1,264,000USD——————
Other Non Cash Items———1,827,000USD—59,000USD-59,000USD3,454,000USD
Unclassified Operating Cash Flow———-1,827,000USD———-3,454,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USDFY 20192019-09-30 · USDFY 20182018-09-30 · USD
Stock Based Compensation11,549,000USD9,438,000USD16,370,000USD18,379,000USD8,231,000USD4,876,906USD6,430,873USD5,517,004USD
Change To Liabilities-6,321,000USD—970,000USD-915,004USD1,194,558USD2,265,954USD1,270,806USD300,292USD
Change In Working Capital-5,378,000USD2,752,000USD2,505,000USD5,361,000USD-706,000USD116,518USD1,301,614USD-846,674USD
Operating Cash Flow-39,044,000USD———————
Financing Cash Flow9,434,000USD———————
Change In Cash-29,610,000USD-18,837,000USD1,866,000USD-2,950,000USD122,859,000USD7,063,388USD-745,008USD-4,509,619USD
End Cash Flow102,577,000USD———————
Net Income—-43,002,000USD-47,505,000USD-47,978,000USD-37,909,000USD-26,280,470USD-26,294,979USD-17,252,736USD
Other Non Cash Items—2,752,000USD845,000USD242USD403USD6,617,779USD35,375USD5,608,734USD
Change To Account Receivables—260,000USD484,000USD5,944,000USD-4,287,000USD-2,206,595USD-772,388USD-231,096USD
Total Cash From Operating Activities—-30,812,000USD-27,785,000USD-24,238,000USD-30,384,000USD-21,287,046USD-18,527,117USD-12,582,406USD
Capital Expenditures—0USD0USD-4USD-4USD-4USD0USD0USD
Free Cash Flow—-30,812,000USD-27,785,000USD-24,238,000USD-30,384,000USD-21,287,046USD-18,527,117USD-12,582,406USD
Total Cash From Financing Activities—11,975,000USD29,651,000USD21,288,000USD153,243,000USD28,350,434USD17,782,109USD8,072,787USD
Issuance Of Capital Stock—11,284,000USD27,875,000USD20,984,667USD153,218,762USD28,754,198USD17,832,109USD8,173,920USD
Begin Period Cash Flow—151,024,000USD149,158,000USD152,108,000USD29,249,000USD22,185,630USD22,930,638USD27,440,257USD
End Period Cash Flow—132,187,000USD151,024,000USD149,158,000USD152,108,000USD29,249,018USD22,185,630USD22,930,638USD
Other Cashflows From Financing Activities—11,975,000USD29,651,000USD-707,000USD24,000USD-403,764USD-50,000USD-101,133USD
Unclassified Operating Cash Flow—-2,752,000USD———-6,617,779USD—-5,608,734USD
Unclassified Financing Cash Flow—-11,284,000USD-27,875,000USD—————
Change To Inventory——-484,000USD-5,944,251USD4,287,491USD2,206,595USD772,388USD0USD
Sale Purchase Of Stock———21,287,980USD153,242,401USD28,350,434USD17,832,109USD8,173,920USD
Cash And Cash Equivalents Changes———-2,949,884USD122,858,727USD7,063,388USD-745,008USD-4,509,619USD
Net Borrowings——————-50,000USD-101,133USD
Depreciation———————0USD
Total Cashflows From Investing Activities———————0USD
Dividends Paid———————0USD
Other Cashflows From Investing Activities———————0USD
SourceDisclosureDeterministicAmendmentLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

No revenue breakdown is currently published for this company.

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.